Evidence map›Paper›PMID 32957713›Full record

SynthesisBiomolecules2020

Mulinane- and Azorellane-Type Diterpenoids: A Systematic Review of Their Biosynthesis, Chemistry, and Pharmacology.

Angel de Jesús Dzul-Beh, Andrés Humberto Uc-Cachón, Jorge Bórquez, Luis A Loyola, Luis Manuel Peña-Rodríguez, Gloria María Molina-Salinas

Abstract readSystematic Review
In one paragraph

Synthesis in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. TacklingBiomolecules · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Angel de Jesús Dzul-BehUnidad de Investigación Médica Yucatán, Unidad Médica de Alta Especialidad Hospital de Especialidades 1 Mérida, Yucatán, Instituto Mexicano del Seguro Social, Mérida 97150, Yucatán, Mexico.ORCID 0000-0002-4971-7833
Andrés Humberto Uc-CachónUnidad de Investigación Médica Yucatán, Unidad Médica de Alta Especialidad Hospital de Especialidades 1 Mérida, Yucatán, Instituto Mexicano del Seguro Social, Mérida 97150, Yucatán, Mexico.ORCID 0000-0003-3845-7930
Jorge BórquezDepartamento de Química, Facultad de Ciencias Básicas, Universidad de Antofagasta, Antofagasta 02800, Chile.
Luis A LoyolaDepartamento de Química, Facultad de Ciencias Básicas, Universidad de Antofagasta, Antofagasta 02800, Chile.
Luis Manuel Peña-RodríguezUnidad de Biotecnología, Centro de Investigación Científica de Yucatán, A.C., Mérida 97205, Yucatán, Mexico.ORCID 0000-0001-6511-5122
Gloria María Molina-SalinasUnidad de Investigación Médica Yucatán, Unidad Médica de Alta Especialidad Hospital de Especialidades 1 Mérida, Yucatán, Instituto Mexicano del Seguro Social, Mérida 97150, Yucatán, Mexico.ORCID 0000-0002-3961-6449

Funding

Consejo Nacional de Ciencia y Tecnología PDCPN2013/213558Universidad de Antofagasta Centro de Costos de Rectoría 1001
6 · The paper itself

Abstract

Mulinane- and azorellane-type diterpenoids have unique tricyclic fused five-, six-, and seven-membered systems and a wide range of biological properties, including antimicrobial, antiprotozoal, spermicidal, gastroprotective, and anti-inflammatory, among others. These secondary metabolites are exclusive constituents of medicinal plants belonging to the

Indexed as

Anti-Bacterial AgentsApiaceaeDiterpenesMicrobial Sensitivity TestsModels, ChemicalMolecular StructurePlant ExtractsPlants, MedicinalAnti-Bacterial AgentsazorellaneDiterpenesmulinanePlant Extractsantimycobacterialantiulcerazorellanediterpenoidsmulinane

Identifiers

PMID32957713
PMCPMC7565077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.